Intensive care units (ICUs) are amazing places. They are for healing the sickest of the sick where every moment is a matter of life and death. Around 90 per cent of people who are admitted into ICUs survive, which is a remarkable achievement and testament to the committed medical teams who fight to keep them alive.
The ICU space itself however, can feel like being in the middle of a war zone. Alarms, bright artificial lights, beeping machines, high anxiety and distressed relatives… The impact of this to ICU patients over a week or more—of stress, sleep deprivation and strange surroundings—can lead to delirium and in many cases ongoing mental health concerns such as post-traumatic stress.
Delirium is a serious condition that results in an acute change in the mental state of critically ill patients, with disturbances to their consciousness, attention, cognition and perception. Symptoms can include terrifying hallucinations or having delusions that staff are trying to harm them.
However, the Critical Care Research Group, supported by The Common Good, Lendlease, Philips, Breadcrumb Digital, and Wilson Architects, are looking to create an ICU space that concentrates on the well-being of the patient, including both their physical condition and their emotional and mental health. The patient’s experience will be at the centre of an innovative bed space design, or ‘Cocoon’, that infuses technology and personalised medicine with best practice architectural and engineering solutions.
Through the clever use of adjustable technology including circadian lighting that mimics natural sunlight; sound masking which uses bed sensors to change background noise levels; flexible architectural design to maximise patient privacy, this approach to critical care will provide a way for the emotional and psychological well-being of the ICU patient to come first so that people not only survive but thrive.
An optimal ICU design can improve patient outcomes, decrease length of stay, reduce the rate of preventable complications, and lower health care costs. Considering that ICU patients aged over 60 have an 80 per cent chance of developing delirium, the Intensive Care Cocoon could revolutionise ICU patient care.
Annalicia is now performing a clinical trial to see if dietary fibre can reduce inflammation in lung cells through healthy gut bacteria.
Walk into the laboratory of the Cardiovascular Molecular and Therapeutics Translational Group and you’ll feel as if you’ve crossed into a unique and exciting dimension of science. Pipes and pumps, tanks filled with water at precisely 37 degrees Celsius to replicate the conditions of the human body, bubbling tubes crossing over one another–Associate Professor Peter Molenaar’s lab is an intriguing sight.